Oxidative Medicine and Cellular Longevity / 2020 / Article / Fig 7

Research Article

A Dihydroflavonoid Naringin Extends the Lifespan of C. elegans and Delays the Progression of Aging-Related Diseases in PD/AD Models via DAF-16

Figure 7

Naringin could not extend the lifespan of long-lived mutants in the nutrition-sensing pathway. (a–d) Survival curves of eat-2, sir2.1, rsks-1,and clk-1 mutants in the control or treated with 50 μM naringin; naringin could not further extend the mean lifespan of C. elegans. Statistical details and repeats of these experiments are summarized in Table S1 (Supplementary information).
(a)
(b)
(c)
(d)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.